Physician profile
John D Hyatt
NPI 1184696346
$57,232.27
in general payments reported to CMS, 2019-2025
13 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2021: $102 · 2022: $21K · 2023: $35K · 2024: $138 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,120.00 |
| Food and Beverage | $571.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $56,330.00 | 2022-2023 | Hillrom - Retinavue Network, Hillrom - Retinavue 700 Imager |
| Regeneron Healthcare Solutions, INC. | $391.98 | 2019-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $103.37 | 2023-2025 | Izervay |
| Genentech USA, INC. | $97.00 | 2022-2025 | Vabysmo |
| Eyepoint US, INC. | $78.22 | 2021 | |
| Abbvie INC. | $77.33 | 2023-2025 | |
| Biogen, INC. | $34.20 | 2023 | |
| Boston Scientific Corporation | $25.39 | 2024 | Wavewriter Alpha Prime 16 |
| Horizon Therapeutics Plc | $24.26 | 2021 | |
| Bausch & Lomb Americas INC. | $20.80 | 2022 | |
| Alimera Sciences, INC. | $18.80 | 2023 | Yutiq |
| Ani Pharmaceuticals, INC. | $18.57 | 2025 | Yutiq |
| Novartis Pharmaceuticals Corporation | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hyatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.